Gene · 3093
Papers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| R306X Mutation in the MECP2 Gene Causes an Atypical Rett Syndrome in a Moroccan Patient: A Case Report. | Clin Pathol | 2022 | 36147795 | PubTator, text mining | PubMed |
| Potential gene identification and pathway crosstalk analysis of age-related macular degeneration. | Front Genet | 2022 | 36147504 | PubTator, text mining | PubMed |
| Designing for Shape Memory in Additive Manufacturing of Cu-Al-Ni Shape Memory Alloy Processed by Laser Powder Bed Fusion. | Materials (Basel) | 2022 | 36143595 | PubTator, text mining | PubMed |
| Crosstalk of Oxidative Phosphorylation-Related Subtypes, Establishment of a Prognostic Signature and Immune Infiltration Characteristics in Colorectal Adenocarcinoma. | Cancers (Basel) | 2022 | 36139663 | PubTator, text mining | PubMed |
| Distinguishing transient from persistent tactile agnosia after partial anterior circulation infarcts - Behavioral and neuroimaging evidence for white matter disconnection. | Neuroimage Clin | 2022 | 36126517 | PubTator, text mining | PubMed |
| Bioinformatics-based identification of key genes and pathways associated with colorectal cancer diagnosis, treatment, and prognosis. | Medicine (Baltimore) | 2022 | 36123948 | PubTator, text mining | PubMed |
| An update regarding the role of WNK kinases in cancer. | Cell Death Dis | 2022 | 36123332 | PubTator, text mining | PubMed |
| Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers. | Front Oncol | 2022 | 36119484 | PubTator, text mining | PubMed |
| A robust CD8+ T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma. | Front Immunol | 2022 | 36119068 | PubTator, text mining | PubMed |
| Investigation of metabolic crosstalk between host and pathogenic Clostridioides difficile via multiomics approaches. | Front Bioeng Biotechnol | 2022 | 36118584 | PubTator, text mining | PubMed |
| Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of "Chuanxiong Rhizoma: Radix Salviae miltiorrhizae" Herb Couples in the Treatment of Preeclampsia. | Evid Based Complement Alternat Med | 2022 | 36118076 | PubTator, text mining | PubMed |
| Is metformin a possible treatment for diabetic neuropathy? | J Diabetes | 2022 | 36117320 | PubTator, text mining | PubMed |
| Neural dynamics of illusory tactile pulling sensations. | iScience | 2022 | 36105590 | PubTator, text mining | PubMed |
| Novel viral splicing events and open reading frames revealed by long-read direct RNA sequencing of adenovirus transcripts. | PLoS Pathog | 2022 | 36095031 | PubTator, text mining | PubMed |
Identification of potential models for predicting progestin insensitivity in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer based on ATAC-Seq and RNA-Seq integrated analysis. | Front Genet | 2022 | 36092919 | PubTator, text mining | PubMed |
| Gene Ontology Capsule GAN: an improved architecture for protein function prediction. | PeerJ Comput Sci | 2022 | 36092003 | PubTator, text mining | PubMed |
| Network pharmacology and experimental analysis to reveal the mechanism of Dan-Shen-Yin against endothelial to mesenchymal transition in atherosclerosis. | Front Pharmacol | 2022 | 36091823 | PubTator, text mining | PubMed |
| Overcoming Resistance: FLT3 Inhibitors Past, Present, Future and the Challenge of Cure. | Cancers (Basel) | 2022 | 36077850 | PubTator, text mining | PubMed |
| Construction of the coexpression network involved in the pathogenesis of thyroid eye disease via bioinformatics analysis. | Hum Genomics | 2022 | 36076300 | PubTator, text mining | PubMed |
| RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma. | J Oncol | 2022 | 36072976 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3093/papers?page=31